InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Waters Mitchell, Directeur Exécutif. Officer active across 1 company, notably Nextgen Healthcare, INC.. Aggregated, 17 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €277k. History available since 1 June 2021. The latest transaction was disclosed on 30 October 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Waters Mitchell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
57,931 sharesCommon StockSEC:0000950170-23-062960:0
3,842 shares@ US$23.8910.8% of flowCommon StockSEC:0001209191-23-054042:0
2,751 shares@ US$23.867.7% of flowCommon StockSEC:0001209191-23-053882:0
5,452 sharesCommon StockSEC:0001209191-23-050498:0
1,503 shares@ US$15.592.7% of flowCommon StockSEC:0001209191-23-033970:0
2,153 shares@ US$18.784.6% of flowCommon StockSEC:0001209191-23-006235:0
9,783 shares@ US$20.5024.9% of flowCommon StockSEC:0001209191-22-056128:0
5,284 shares@ US$19.8413.2% of flowCommon StockSEC:0001209191-22-055860:0
25,562 shares0Common StockSEC:0001209191-22-055159:0
2,751 shares@ US$19.026.5% of flowCommon StockSEC:0001209191-22-054852:0
3,889 shares@ US$20.009.6% of flowCommon StockSEC:0001209191-22-054653:0
5,452 sharesCommon StockSEC:0001209191-22-051279:0
1,124 shares@ US$18.1211.9% of flowCommon StockSEC:0001209191-22-033659:0
1,813 shares@ US$19.174.2% of flowCommon StockSEC:0001209191-22-006512:0
35,152 shares0Common StockSEC:0001209191-21-062915:0
2,751 shares@ US$14.934.8% of flowCommon StockSEC:0001209191-21-061952:0
306 shares@ US$16.590.6% of flowCommon StockSEC:0001209191-21-037878:0
17 of 17 declarations
About Waters Mitchell
Waters Mitchell is a Director Exécutif and EVP, Commercial Growth at Nextgen Healthcare, INC. The 17 filings on record, covering the period from 2021-06-03 to 2023-11-13, show sales of EUR 277250 and the modal transaction nature is Retenue fiscale.
